Bio-Rad Laboratories Inc (BIO-B) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Bio-Rad Laboratories Inc (BIO-B) has a cash flow conversion efficiency ratio of 0.016x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($116.50 Million) by net assets ($7.13 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bio-Rad Laboratories Inc - Cash Flow Conversion Efficiency Trend (1989–2024)
This chart illustrates how Bio-Rad Laboratories Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read BIO-B current and long-term liabilities for a breakdown of total debt and financial obligations.
Bio-Rad Laboratories Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bio-Rad Laboratories Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MD Pictures Tbk PT
JK:FILM
|
-0.015x |
|
Acadia Healthcare Company Inc
NASDAQ:ACHC
|
0.022x |
|
Alexander & Baldwin Holdings Inc
NYSE:ALEX
|
0.013x |
|
EVEREST MED.LTD DL-0001
F:6HN
|
N/A |
|
Yapp Automotive Systems Co Ltd
SHG:603013
|
0.065x |
|
COSMO Pharmaceuticals SA
SW:COPN
|
-0.026x |
|
QCR Holdings Inc
NASDAQ:QCRH
|
0.043x |
|
Hyundai Green Food Co Ltd
KO:005440
|
0.008x |
Annual Cash Flow Conversion Efficiency for Bio-Rad Laboratories Inc (1989–2024)
The table below shows the annual cash flow conversion efficiency of Bio-Rad Laboratories Inc from 1989 to 2024. For the full company profile with market capitalisation and key ratios, see Bio-Rad Laboratories Inc (BIO-B) market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $6.57 Billion | $455.20 Million | 0.069x | +61.54% |
| 2023-12-31 | $8.74 Billion | $374.94 Million | 0.043x | +112.11% |
| 2022-12-31 | $9.62 Billion | $194.45 Million | 0.020x | -58.66% |
| 2021-12-31 | $13.69 Billion | $669.46 Million | 0.049x | -17.38% |
| 2020-12-31 | $9.88 Billion | $584.97 Million | 0.059x | -25.58% |
| 2019-12-31 | $5.76 Billion | $457.90 Million | 0.080x | +12.04% |
| 2018-12-31 | $4.02 Billion | $285.49 Million | 0.071x | +99.82% |
| 2017-12-31 | $2.93 Billion | $104.14 Million | 0.036x | -57.58% |
| 2016-12-31 | $2.58 Billion | $216.07 Million | 0.084x | +12.04% |
| 2015-12-31 | $2.49 Billion | $186.21 Million | 0.075x | -40.22% |
| 2014-12-31 | $2.19 Billion | $273.31 Million | 0.125x | +61.71% |
| 2013-12-31 | $2.19 Billion | $169.14 Million | 0.077x | -41.50% |
| 2012-12-31 | $2.02 Billion | $266.48 Million | 0.132x | -12.22% |
| 2011-12-31 | $1.74 Billion | $262.74 Million | 0.151x | +2.71% |
| 2010-12-31 | $1.54 Billion | $225.91 Million | 0.147x | -42.29% |
| 2009-12-31 | $1.28 Billion | $325.07 Million | 0.254x | +42.17% |
| 2008-12-31 | $1.07 Billion | $191.37 Million | 0.179x | -9.34% |
| 2007-12-31 | $971.69 Million | $191.58 Million | 0.197x | +36.67% |
| 2006-12-31 | $819.54 Million | $118.23 Million | 0.144x | -12.34% |
| 2005-12-31 | $657.97 Million | $108.28 Million | 0.165x | -20.20% |
| 2004-12-31 | $596.89 Million | $123.09 Million | 0.206x | -19.89% |
| 2003-12-31 | $495.81 Million | $127.64 Million | 0.257x | -6.75% |
| 2002-12-31 | $383.09 Million | $105.76 Million | 0.276x | -21.23% |
| 2001-12-31 | $283.88 Million | $99.50 Million | 0.350x | +253.59% |
| 2000-12-31 | $244.62 Million | $24.25 Million | 0.099x | -51.52% |
| 1999-12-31 | $220.10 Million | $45.00 Million | 0.204x | +60.49% |
| 1998-12-31 | $214.30 Million | $27.30 Million | 0.127x | +18.76% |
| 1997-12-31 | $196.70 Million | $21.10 Million | 0.107x | -40.71% |
| 1996-12-31 | $183.50 Million | $33.20 Million | 0.181x | -25.59% |
| 1995-12-31 | $157.10 Million | $38.20 Million | 0.243x | -34.65% |
| 1994-12-31 | $129.80 Million | $48.30 Million | 0.372x | +82.42% |
| 1993-12-31 | $110.30 Million | $22.50 Million | 0.204x | +446.18% |
| 1992-12-31 | $107.10 Million | $4.00 Million | 0.037x | -17.29% |
| 1991-12-31 | $90.80 Million | $4.10 Million | 0.045x | -69.74% |
| 1990-12-31 | $81.10 Million | $12.10 Million | 0.149x | +4.90% |
| 1989-12-31 | $68.90 Million | $9.80 Million | 0.142x | -- |
About Bio-Rad Laboratories Inc
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. It operates through two segments, Life Science and Clinical Diagnostics. The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biolog… Read more